<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21294" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Erythema Elevatum Diutinum</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Newburger</surname>
            <given-names>Jessica</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schmieder</surname>
            <given-names>George J.</given-names>
          </name>
          <aff>Orange Park</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jessica Newburger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>George Schmieder declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21294.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Erythema elevatum diutinum is a rare, chronic dermatosis characterized by red&#x02013;violet to red&#x02013;brown papules, plaques, and nodules that favor extensor surfaces. Lesions often are asymptomatic, though some patients may experience pain or a burning sensation. Non-cutaneous symptoms include constitutional symptoms such as arthralgia and fever. Although erythema elevatum diutinum is benign, it can occur in association with infections, hematologic abnormalities, autoimmune diseases, or other conditions. Spontaneous resolution commonly occurs after 5 to 10 years. This activity describes the pathophysiology, evaluation, and management of erythema elevatum diutinum and stresses the role of the interprofessional team in the care of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of erythema elevatum diutinum.</p></list-item><list-item><p>Describe the presentation of a patient with erythema elevatum diutinum.</p></list-item><list-item><p>Outline the management options available for erythema elevatum diutinum.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication to advance the evaluation and management of erythema elevatum diutinum and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21294&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21294">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21294.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Erythema elevatum&#x000a0;diutinum (EED) is a rare, chronic dermatosis that is characterized by red&#x02013;violet to red&#x02013;brown papules, plaques, and nodules that favor the extensor surfaces. Lesions often are asymptomatic, though patients may experience pain or a burning sensation. Extracutaneous symptoms include arthralgia, fever, or other constitutional symptoms. The condition is benign in nature but may be associated with infections, hematologic abnormalities, autoimmune diseases, or other conditions. Spontaneous resolution often occurs after 5 to 10 years.<xref ref-type="bibr" rid="article-21294.r1">[1]</xref><xref ref-type="bibr" rid="article-21294.r2">[2]</xref></p>
      </sec>
      <sec id="article-21294.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The cause of EED is not well understood, but it is thought to be secondary to immune complex deposition in dermal blood vessels, which results in complement fixation and subsequent inflammation. The findings appreciated on examination of the skin may be seen due to deposition of immune complexes in small vessels, which leads to activation of complement, the influx of neutrophils, and the emission of destructive enzymes. Antineutrophil cytoplasmic antibodies may be pathogenic in EED. Furthermore, the initiation of EED may occur via activation of cytokines (interleukin-8), which causes selective recruitment of leukocytes to blood vessels. This leads to repetitive damage to the vessels and ultimately develops into fibrosis.&#x000a0;<xref ref-type="bibr" rid="article-21294.r3">[3]</xref><xref ref-type="bibr" rid="article-21294.r2">[2]</xref><xref ref-type="bibr" rid="article-21294.r1">[1]</xref></p>
      </sec>
      <sec id="article-21294.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>EED is rare, with descriptions of only several hundred cases in the literature. The disease can develop at any age but is more common in the fourth and sixth decades. An earlier onset occurs more often in the setting of HIV infection. The male-to-female ratio is approximately equal, and no racial predilection has been observed.&#x000a0;<xref ref-type="bibr" rid="article-21294.r1">[1]</xref></p>
      </sec>
      <sec id="article-21294.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Although the etiology of EED is unknown, circulating immune complexes, with repeated deposition, associated inflammation, and partial healing are thought to represent the underlying pathogenesis. Immune complex deposition results in complement activation, neutrophilic infiltration, and the release of destructive enzymes. This results in fibrin deposition in and around small dermal vessels during the later stages of the disease.<xref ref-type="bibr" rid="article-21294.r3">[3]</xref></p>
        <p>EED has been described in association with a number of systemic diseases. It is frequently found with hematologic disorders, such as IgA monoclonal gammopathy, myelodysplasia, myeloproliferative disorders, paraproteinemia, and hairy cell leukemia. Infections from group B streptococci, HIV, syphilis, and viral hepatitis are commonly associated with EED as well as autoimmune conditions, such as celiac disease, Crohn disease, systemic lupus erythematosus and rheumatoid arthritis. In the study performed by Katz et al., two of five patients with EED demonstrated a prevalence of recurrent bacterial infections that were usually Streptococcal in nature. They also demonstrated increased C1q binding in three of five patients, a finding suggestive of the presence of circulating immune complexes.&#x000a0;<xref ref-type="bibr" rid="article-21294.r4">[4]</xref><xref ref-type="bibr" rid="article-21294.r1">[1]</xref><xref ref-type="bibr" rid="article-21294.r5">[5]</xref></p>
      </sec>
      <sec id="article-21294.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically, EED is characterized by early changes of a leukocytoclastic vasculitis with a polymorphonuclear cell infiltrate and deposition of fibrin in the superficial and mid dermis. Polymorphonuclear cells, macrophages, histiocytes, and eosinophils may surround the blood vessels. These&#x000a0;infiltrates may accumulate between collagen bundles. A papillary edema also may be seen in early lesions as a reflection of clinical pseudo vesiculation.<xref ref-type="bibr" rid="article-21294.r4">[4]</xref><xref ref-type="bibr" rid="article-21294.r6">[6]</xref></p>
        <p>Over time, the infiltrate contains more histiocytes and granulation tissue, and spindle cell proliferation may be seen. Extracellular cholesterol deposits may be observed in the fibrotic tissue. The fibrosis of late lesions is most likely a result of chronic dermal injury of leukocytoclastic vasculitis. Direct immunofluorescence may reveal changes consistent with vasculitis, such as fibrin deposits, intravascularly and perivascularly, complement, and immunoglobulins (IgG, IgA, IgM).&#x000a0;<xref ref-type="bibr" rid="article-21294.r7">[7]</xref><xref ref-type="bibr" rid="article-21294.r5">[5]</xref><xref ref-type="bibr" rid="article-21294.r8">[8]</xref></p>
      </sec>
      <sec id="article-21294.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>On exam, lesions of EED present as red&#x02013;brown, yellowish, or violaceous papules, plaques, or nodules. They typically are symmetrically distributed and favor acral and periarticular sites, specifically the extensor surfaces of the elbows, knees, ankles, hands, and fingers. Additional sites of involvement include the face, retro-auricular area, axillae, buttocks, and genitalia. The trunk is usually spared. The lesions usually feel firm and are mobile over the underlying tissue, except typically on the palms and the soles.&#x000a0;<xref ref-type="bibr" rid="article-21294.r9">[9]</xref><xref ref-type="bibr" rid="article-21294.r10">[10]</xref></p>
        <p>Initially, the lesions are erythematous and soft but with time become red&#x02013;brown or violaceous in color and firm to palpation secondary to fibrosis. Over the course of the disease process, the lesions can change in color as well as an increase in size and quantity.&#x000a0;<xref ref-type="bibr" rid="article-21294.r2">[2]</xref><xref ref-type="bibr" rid="article-21294.r11">[11]</xref></p>
        <p>Typically, the lesions are asymptomatic, but there have been reports of patients who experienced pruritus and burning or tingling sensations, especially early in the disease course. EED in the setting of HIV infection is characterized by nodular lesions, used palmoplantar, that progress to form bulky masses. Arthralgias may develop in underlying joints, but extracutaneous involvement is extremely rare. The exception includes ocular abnormalities such as scleritis, uveitis, autoimmune keratolysis, and peripheral keratitis.&#x000a0;<xref ref-type="bibr" rid="article-21294.r2">[2]</xref><xref ref-type="bibr" rid="article-21294.r12">[12]</xref></p>
        <p>The disease is chronic and has a relapsing and remitting course. The majority of cases resolve spontaneously over a period of 5 to 10 years, but the disease can last up to 40 years. EED lesions do not typically leave scars but can resolve with areas of hyperpigmentation or hypopigmentation. No mortality due to EED has been reported.&#x000a0;<xref ref-type="bibr" rid="article-21294.r3">[3]</xref><xref ref-type="bibr" rid="article-21294.r13">[13]</xref></p>
      </sec>
      <sec id="article-21294.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A skin biopsy is the most useful study for the diagnosis of EED. Electron microscopy is not a necessary diagnostic tool but would show changes and features of leukocytoclastic vasculitis. The erythrocyte sedimentation rate in patients with EED is often elevated. Antineutrophil cytoplasmic antibodies of IgA class may be helpful as a marker of disease, and Immunoelectrophoresis can also be used to identify possible gammopathies.<xref ref-type="bibr" rid="article-21294.r14">[14]</xref><xref ref-type="bibr" rid="article-21294.r5">[5]</xref></p>
      </sec>
      <sec id="article-21294.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of EED is difficult because the disorder follows a chronic and recurrent course.</p>
        <p>Dapsone, a sulfonamide antibiotic that impairs neutrophil chemotaxis and function, is the most effective treatment agent, but relapse is common upon discontinuation. It is also ineffective in nodular lesions, due to the fibrosis of the lesions. Other therapies include NSAIDs, niacinamide, tetracyclines, chloroquine, colchicine, and plasmapheresis. Topical and intralesional corticosteroids may be helpful for mild cases, but systemic corticosteroids are rarely indicated.<xref ref-type="bibr" rid="article-21294.r14">[14]</xref></p>
        <p>Antimicrobials, such as tetracyclines, are thought to alter neutrophil chemotaxis and phagocytosis, suppressing neutrophil chemotaxis and random migration in vivo. Niacinamide, an in vitro specific inhibitor of cyclic AMP, acts as a transfer factor needed for the suppression of antigen-induced lymphocyte transformation. It is relatively non-toxic and can be used in the treatment of neutrophil-driven disorders, with fewer side effects than dapsone. Local surgical excision can be beneficial for localized fibrotic nodules of EED. Regardless of treatment, the recurrence rate of EED is high if the underlying triggering factors are not controlled.<xref ref-type="bibr" rid="article-21294.r3">[3]</xref><xref ref-type="bibr" rid="article-21294.r2">[2]</xref><xref ref-type="bibr" rid="article-21294.r1">[1]</xref></p>
      </sec>
      <sec id="article-21294.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute febrile neutrophilic dermatosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dermatofibroma</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythema multiforme</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Granuloma annulare</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Granuloma faciale</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Multicentric reticulohistiocytosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pyoderma gangrenosum</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Xanthomas</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21294.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>&#x000a0;EED is a skin disorder that is best managed by an interprofessional team that includes nurses and pharmacists. The diagnosis usually required a biopsy. However, treatment of EED is not adequate once it is established. The triggers or the primary cause must be treated; with all treatment recurrences are common. It often takes years for the skin disorder to resolve.</p>
      </sec>
      <sec id="article-21294.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21294&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21294">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/erythema-elevatum-diutinum/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21294">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21294/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21294">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21294.s13">
        <title>References</title>
        <ref id="article-21294.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibson</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>el-Azhary</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum.</article-title>
            <source>Clin Dermatol</source>
            <year>2000</year>
            <season>May-Jun</season>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-9</page-range>
            <pub-id pub-id-type="pmid">10856661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowd</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Munro</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum.</article-title>
            <source>J R Soc Med</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>76</volume>
            <issue>4</issue>
            <fpage>310</fpage>
            <page-range>310-3</page-range>
            <pub-id pub-id-type="pmid">6601714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bansal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aron</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rajnish</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Erythema Elevatum Diutinum.</article-title>
            <source>Am J Med Sci</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>353</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <pub-id pub-id-type="pmid">28183422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wahl</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Bouldin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum: clinical, histopathologic, and immunohistochemical characteristics of six patients.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>397</fpage>
            <page-range>397-400</page-range>
            <pub-id pub-id-type="pmid">16148408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chow</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Benny</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Coupe</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Dodd</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Ongley</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with intermittent plasma exchange.</article-title>
            <source>Arch Dermatol</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>11</issue>
            <fpage>1360</fpage>
            <page-range>1360-4</page-range>
            <pub-id pub-id-type="pmid">8915315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkinson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>English</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Wilson-Jones</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Winkelmann</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum: a clinicopathological study.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>87</fpage>
            <page-range>87-93</page-range>
            <pub-id pub-id-type="pmid">1516248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yiannias</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>el-Azhary</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-44</page-range>
            <pub-id pub-id-type="pmid">1732334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Archimandritis</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Fertakis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alegakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bartsokas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Melissinos</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum and IgA myeloma: an interesting association.</article-title>
            <source>Br Med J</source>
            <year>1977</year>
            <month>Sep</month>
            <day>03</day>
            <volume>2</volume>
            <issue>6087</issue>
            <fpage>613</fpage>
            <page-range>613-4</page-range>
            <pub-id pub-id-type="pmid">902003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>LeLeux</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Diwan</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>JAAD Grand Rounds quiz. Adult with red-brown nodules and plaques.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>469</fpage>
            <page-range>469-471</page-range>
            <pub-id pub-id-type="pmid">21763595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mraz</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Newcomer</surname>
                <given-names>VD</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum. Presentation of a case and evaluation of laboratory and immunological status.</article-title>
            <source>Arch Dermatol</source>
            <year>1967</year>
            <month>Sep</month>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>235</fpage>
            <page-range>235-46</page-range>
            <pub-id pub-id-type="pmid">4166920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>High</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Hoang</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cockerell</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Late-stage nodular erythema elevatum diutinum.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>764</fpage>
            <page-range>764-7</page-range>
            <pub-id pub-id-type="pmid">14512939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jose</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Marfatia</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum in acquired immune deficiency syndrome: Can it be an immune reconstitution inflammatory syndrome?</article-title>
            <source>Indian J Sex Transm Dis AIDS</source>
            <year>2016</year>
            <season>Jan-Jun</season>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-4</page-range>
            <pub-id pub-id-type="pmid">27190420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramsey</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tschen</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum.</article-title>
            <source>Cutis</source>
            <year>1984</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-3</page-range>
            <pub-id pub-id-type="pmid">6467974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21294.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Gallin</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Hertz</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Fauci</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Lawley</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Erythema elevatum diutinum: skin and systemic manifestations, immunologic studies, and successful treatment with dapsone.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1977</year>
            <month>Sep</month>
            <volume>56</volume>
            <issue>5</issue>
            <fpage>443</fpage>
            <page-range>443-55</page-range>
            <pub-id pub-id-type="pmid">142192</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
